An article covering opinions on the new suicide risk warnings for young adults on antidepressant medications favors the belief that the new warnings will not significantly alter the amount of prescriptions written for this age group. Although there has been some growing public concern about the high rates of children and young adults on psychiatric medications and the hopes of some mental health advocates to reduce reliance on medication for long-term treatment, the some experts believed that rates of prescriptions have leveled-off and become stable since the warnings were introduced for children.

I think that this issue provides one of the best current intersections of psychological treatment, public health, and corporate interests that exists at the present time. It highlights how difficult it can be for governing bodies to find a balance between competing interests.

Comments

This post currently has one comment. You can read the comments or leave your own thoughts on our new comments page.

Trackbacks

No trackbacks yet to this post.

    Last reviewed: By John M. Grohol, Psy.D. on 6 May 2007
    Published on PsychCentral.com. All rights reserved.